The FDA released a guidance document for comment purposes.
The DSCSA (Title II of Public Law 113 - 54) was signed into law on November 27, 2013. Section 202 of the DSCSA added section 582 to the FD&C Act, which established product tracing requirements for manufacturers, repackagers, wholesale distributors, and dispensers of most prescription drugs in a finished dosage form for administration to a patient without substantial further manufacturing (products). The DSCSA phases in its new requirements over a period of 10 years.
Full guidance document:https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM586509.pdf
Back to overview
+49 721 6634 330 firstname.lastname@example.org
Or get in touch with our specialists via: